Explainer-Who in the US Benefits From $35 Insulin?
Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...
Reuters13d
$35 insulin: Who in the US benefits?
Novo said last year it would pull its Levemir insulin from the U.S. market at the end of 2024, months after cutting its price ...
USA Today20d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The company said it would discontinue the insulin Levemir due to global manufacturing ... insulin products and more than 800 million insulin pens a year. "Not only are we not winding down our ...
pharmaphorum26d
Lilly and Boehringer biosimilar undercuts Lantus by 15%
The list price of Basaglar will be $316.85 for a pack of five pens, 15% below the list price ... undercutting the long-acting Levemir (insulin detemir) by 21% and Tresiba (insulin degludec ...
Investing14d
Explainer-Who in the US benefits from $35 insulin?
Novo said last year it would pull its Levemir insulin from the U.S. market at the end of 2024, months after cutting its price by 65% to $108 a vial and $162 for a 5-pack of injector pens.
AZ Central20d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The company said it would discontinue the insulin Levemir due to global manufacturing constraints ... makes more than a dozen ...